Position in MSLE
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,295,463
New position
Shares Held
230,100
first reported quarter
Ownership
1.10%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#14
of 31 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Empery Asset Management, LP holds $53,120,730 across 6 Biotechnology names. MSLE ranks #4 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XFOR |
X4 Pharmaceuticals, Inc
|
8,944,118 | $36,939,207 | |
| 2 | DTIL |
Precision Biosciences Inc
|
1,968,879 | $10,828,834 | |
| 3 | TNYA |
Tenaya Therapeutics, Inc.
|
4,286,933 | $2,966,557 | |
| 4 | MSLE |
Satellos Bioscience Inc.
This page
|
230,100 | $1,295,463 | |
| 5 | PMN |
ProMIS Neurosciences Inc.
|
60,353 | $766,483 | |
| 6 | BNTC |
Benitec Biopharma Inc.
|
30,440 | $324,186 |
All Filings in MSLE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,295,463 | 230,100 | Shares | Sole | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||